Susquehanna International Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-348,400
| Closed | -$13.7M | – | 13483 |
|
|
2023
Q2 | $13.7M | Sell |
348,400
-39,400
| -10% | -$1.39M | ﹤0.01% | 2119 |
|
|
2023
Q1 | $9.44M | Buy |
387,800
+42,300
| +12% | +$926K | ﹤0.01% | 2536 |
|
|
2022
Q4 | $7.4M | Sell |
345,500
-272,900
| -44% | -$5.82M | ﹤0.01% | 2683 |
|
|
2022
Q3 | $11.1M | Sell |
618,400
-19,100
| -3% | -$251K | ﹤0.01% | 2029 |
|
|
2022
Q2 | $6.13M | Buy |
637,500
+175,000
| +38% | +$2.2M | ﹤0.01% | 2861 |
|
|
2022
Q1 | $7.78M | Buy |
462,500
+160,300
| +53% | +$2.37M | ﹤0.01% | 2901 |
|
|
2021
Q4 | $5.05M | Sell |
302,200
-365,600
| -55% | -$5.99M | ﹤0.01% | 3718 |
|
|
2021
Q3 | $10.8M | Buy |
667,800
+519,200
| +349% | +$5.65M | ﹤0.01% | 2744 |
|
|
2021
Q2 | $938K | Sell |
148,600
-339,000
| -70% | -$2.19M | ﹤0.01% | 7947 |
|
|
2021
Q1 | $3.01M | Buy |
487,600
+35,200
| +8% | +$214K | ﹤0.01% | 4944 |
|
|
2020
Q4 | $3.13M | Buy |
452,400
+36,600
| +9% | +$234K | ﹤0.01% | 4236 |
|
|
2020
Q3 | $2.35M | Buy |
415,800
+314,400
| +310% | +$1.5M | ﹤0.01% | 4312 |
|
|
2020
Q2 | $517K | Buy |
101,400
+33,300
| +49% | +$139K | ﹤0.01% | 7295 |
|
|
2020
Q1 | $234K | Sell |
68,100
-135,900
| -67% | -$794K | ﹤0.01% | 8418 |
|
|
2019
Q4 | $1.75M | Buy |
+204,000
| New | +$729K | ﹤0.01% | 4544 |
|
|
2019
Q1 | – | Sell |
-13,600
| Closed | -$16K | – | 10120 |
|
|
2018
Q4 | $16K | Sell |
13,600
-14,700
| -52% | -$28.5K | ﹤0.01% | 8710 |
|
|
2018
Q3 | $67K | Buy |
28,300
+7,200
| +34% | +$17.9K | ﹤0.01% | 8755 |
|
|
2018
Q2 | $58K | Buy |
21,100
+8,500
| +67% | +$23.4K | ﹤0.01% | 9233 |
|
|
2018
Q1 | $35K | Sell |
12,600
-3,000
| -19% | -$8.7K | ﹤0.01% | 9050 |
|
|
2017
Q4 | $49K | Sell |
15,600
-5,100
| -25% | -$14.3K | ﹤0.01% | 8912 |
|
|
2017
Q3 | $58K | Sell |
20,700
-62,500
| -75% | -$169K | ﹤0.01% | 8508 |
|
|
2017
Q2 | $213K | Buy |
83,200
+22,200
| +36% | +$60.5K | ﹤0.01% | 8188 |
|
|
2017
Q1 | $223K | Sell |
61,000
-211,100
| -78% | -$892K | ﹤0.01% | 7859 |
|
|
2016
Q4 | $1.31M | Buy |
272,100
+100,300
| +58% | +$2.98M | ﹤0.01% | 4948 |
|
|
2016
Q3 | $7.92M | Buy |
171,800
+113,400
| +194% | +$6.4M | ﹤0.01% | 1735 |
|
|
2016
Q2 | $2.98M | Sell |
58,400
-42,300
| -42% | -$2.1M | ﹤0.01% | 2940 |
|
|
2016
Q1 | $4.26M | Buy |
100,700
+31,300
| +45% | +$1.59M | ﹤0.01% | 2511 |
|
|
2015
Q4 | $5.45M | Buy |
69,400
+51,800
| +294% | +$3M | ﹤0.01% | 2425 |
|
|
2015
Q3 | $713K | Sell |
17,600
-18,700
| -52% | -$991K | ﹤0.01% | 6428 |
|
|
2015
Q2 | $1.89M | Buy |
36,300
+6,000
| +20% | +$298K | ﹤0.01% | 4835 |
|
|
2015
Q1 | $1.41M | Buy |
30,300
+2,700
| +10% | +$140K | ﹤0.01% | 5058 |
|
|
2014
Q4 | $1.24M | Sell |
27,600
-9,500
| -26% | -$399K | ﹤0.01% | 5434 |
|
|
2014
Q3 | $1.44M | Sell |
37,100
-3,800
| -9% | -$149K | ﹤0.01% | 5205 |
|
|
2014
Q2 | $1.73M | Buy |
40,900
+29,200
| +250% | +$1.07M | ﹤0.01% | 4938 |
|
|
2014
Q1 | $418K | Buy |
11,700
+1,700
| +17% | +$57.3K | ﹤0.01% | 7034 |
|
|
2013
Q4 | $324K | Buy |
+10,000
| New | +$297K | ﹤0.01% | 7464 |
|
Susquehanna International Group's ISEE Position: Q3 2023 in Review
Susquehanna International Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,992 shares — an estimated $3.74M sold.
Susquehanna International Group first reported a position in ISEE in Q4 2013 and held it in 35 quarters. The position peaked at $9.19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Susquehanna International Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 94,992 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.74M.
- Susquehanna International Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 35 quarters.
- Susquehanna International Group's IVERIC bio, Inc. Common Stock position peaked at $9.19M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.